Katie J. Suda

Katie J. Suda

Auto-generated profile, based on publicly available information

Katie J. Suda

University of Pittsburgh School of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KKKatherine Callaway Kim
Katherine Callaway Kim
SRScott D. Rothenberger
Scott D. Rothenberger
MTMina Tadrous
Mina Tadrous
IHInmaculada Hernandez
Inmaculada Hernandez
WGWalid F. Gellad
Walid F. Gellad
KSKatie J. Suda
Katie J. Suda
Importance: Drug shortages are a chronic and worsening issue that compromises patient safety. Despite the destabilizing impact of the COVID-19 pandemic on pharmaceutical production, it remains unclear whether issues affecting the drug supply chain were more likely to result in meaningful shortages during the pandemic.Objective: To estimate the proportion of supply chain issue reports associated with drug shortages overall and with the COVID-19 pandemic.Design, Setting, and Participants: This longitudinal cross-sectional study used data from the IQVIA Multinational Integrated Data Analysis database, comprising more than 85% of drug purchases by US pharmacies from wholesalers and manufacturers, from 2017 to 2021. Data were analyzed from January to May 2023.Exposure: Presence of a supply chain issue report to the US Food and Drug Administration or the American Society of Health-Systems Pharmacists (ASHP).Main Outcomes and Measures: The main outcome was drug shortage, defined as at least 33% decrease in units purchased within 6 months of a supply chain issue report. Random-effects logistic regression models compared the marginal odds of shortages for drugs with vs without reports. Interaction terms assessed heterogeneity prior to vs during the COVID-19 pandemic and by drug characteristics (formulation, age, essential medicine status, clinician- vs self-administered, sales volume, and number of manufacturers).Results: A total of 571 drugs exposed to 731 supply chain issue reports were matched to 7296 comparison medications with no reports. After adjusting for drug characteristics, 13.7% (95% CI, 10.4%-17.8%) of supply chain issue reports were associated with subsequent drug shortages vs 4.1% (95% CI, 3.6%-4.8%) of comparators (marginal odds ratio [mOR], 3.7 [95% CI, 2.6-5.1]). Shortages increased among both drugs with and without reports in February to April 2020 (34.2% of drugs with supply chain issue reports and 9.5% of comparison drugs; mOR, 4.9 [95% CI, 2.1-11.6]), and then decreased after May 2020 (9.8% of drugs with reports and 3.6% of comparison drugs; mOR, 2.9 [95% CI, 1.6-5.3]). Significant associations were identified by formulation (parenteral mOR, 1.9 [95% CI, 1.1-3.2] vs oral mOR, 5.4 [95% CI, 3.3-8.8]; P for interaction = .008), WHO essential medicine status (essential mOR, 2.2 [95% CI, 1.3-5.2] vs nonessential mOR, 4.6 [95% CI, 3.2-6.7]; P = .02), and for brand-name vs generic status (brand-name mOR, 8.1 [95% CI, 4.0-16.0] vs generic mOR, 2.4 [95% CI, 1.7-3.6]; P = .002).Conclusions and Relevance: In this national cross-sectional study, supply chain issues associated with drug shortages increased at the beginning of the COVID-19 pandemic. Ongoing policy work is needed to protect US drug supplies from future shocks and to prioritize clinically valuable drugs at greatest shortage risk.

1 June 2020 in Currents in Pharmacy Teaching and Learning
Verified
Journal Article
Closed access
LHLeslie A. Hamilton
Leslie A. Hamilton
KSKatie J. Suda
Katie J. Suda
RHR. Eric Heidel
R. Eric Heidel
SMSharon L.K. McDonough
Sharon L.K. McDonough
MHMolly E. Hunt
Molly E. Hunt
AFAndrea S. Franks
Andrea S. Franks

1 April 2020 in American Journal of Preventive Medicine
Verified
Journal Article
Open access
KSKatie J. Suda
Katie J. Suda
JZJifang Zhou
Jifang Zhou
SRSusan A. Rowan
Susan A. Rowan
JMJessina C. McGregor
Jessina C. McGregor
RPRosanne I. Perez
Rosanne I. Perez
GCGregory S. Calip
Gregory S. Calip
Dentists prescribe 1 in 10 opioid prescriptions in the U.S. When opioids are necessary, national guidelines recommend the prescription of low-dose opioids for a short duration. This study assesses the appropriate prescribing of opioids by dentists before guideline implementation. The authors performed a cross-sectional analysis of a population-based sample of 542,958 U.S. commercial dental patient visits between 2011 and 2015 within the Truven Health MarketScan Research Databases (data analysis October 2018‒April 2019). Patients with recent hospitalization, active cancer treatment, or chronic pain conditions were excluded. Prescription opioids were ascertained using pharmacy claims data with standardized morphine equivalents and recorded days' supply. Appropriate prescribing was determined from the 2016 Centers for Disease Control and Prevention guidelines for pain management based on a recommended 3 days' supply of opioid medication and anticipated post-procedural pain. Twenty-nine percent of prescribed opioids exceeded the recommended morphine equivalents for appropriate management of acute pain. Approximately half (53%) exceeded the recommended days' supply. Patients aged 18-34 years, men, patients residing in the Southern U.S., and those receiving oxycodone were most likely to have opioids prescribed inappropriately. The proportion of opioids that exceed the recommended morphine equivalents increased over the study period, whereas opioids exceeding the recommended days' supply remained unchanged. Between 1 in 4 and 1 in 2 opioids prescribed to adult dental patients are overprescribed. Judicious opioid-prescribing interventions should be tailored to oral health conditions and dentists.

11 November 2020 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
AGAlan E. Gross
Alan E. Gross
KSKatie J. Suda
Katie J. Suda
JZJifang Zhou
Jifang Zhou
GCGregory S. Calip
Gregory S. Calip
SRSusan A. Rowan
Susan A. Rowan
JMJessina C. McGregor
Jessina C. McGregor

7 January 2022 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
CHColin C. Hubbard
Colin C. Hubbard
CECharlesnika T. Evans
Charlesnika T. Evans
GCGregory Sampang Calip
Gregory Sampang Calip
JZJifang Zhou
Jifang Zhou
SRSusan A. Rowan
Susan A. Rowan
KSKatie J. Suda
Katie J. Suda

22 February 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KSKatie J. Suda
Katie J. Suda
MFMargaret A. Fitzpatrick
Margaret A. Fitzpatrick
GGGretchen Gibson
Gretchen Gibson
MJM. Marianne Jurasic
M. Marianne Jurasic
LPLinda Poggensee
Linda Poggensee
CECharlesnika T. Evans
Charlesnika T. Evans
Objective: To determine prophylaxis appropriateness by Veterans’ Affairs (VA) dentists.Design: A cross-sectional study of dental visits, 2015–2019.Methods: Antibiotics within 7 days before a visit in the absence of an oral infection were included. Appropriate antibiotic prophylaxis was defined as visits with gingival manipulation and further delineated into narrow and broad definitions based on comorbidities. The primary analysis applied a narrow definition of appropriate prophylaxis: cardiac conditions at the highest risk of an adverse outcome from endocarditis. The secondary analysis included a broader definition: cardiac or immunocompromising condition or tooth extractions and/or implants. Multivariable log-linear Poisson generalized estimating equation regression was used to assess the association between covariates and unnecessary prophylaxis prescriptions.Results: In total, 358,078 visits were associated with 369,102 antibiotics. The median prescription duration was 7 days (IQR, 7–10); only 6.5% were prescribed for 1 day. With the narrow definition, 15% of prophylaxis prescriptions were appropriate, which increased to 72% with the broader definition. Prophylaxis inconsistent with guidelines increased over time. For the narrow definition, Black (vs White) race, Latine (vs non-Latine) ethnicity, and visits located in the West census region were associated with unnecessary prophylaxis. Variables associated with a lower risk were older age, prosthetic joints, immunocompromising condition, and rural location.Conclusions: Of every 6 antibiotic prophylaxis prescriptions, 5 were inconsistent with guidelines. Improving prophylaxis appropriateness and shortening duration may have substantial implications for stewardship. Guidelines should state whether antibiotic prophylaxis is indicated for extractions, implants, and immunocompromised patients.